For patients with chronic urticaria (CU), the use of acupuncture was found to be a beneficial adjunctive therapy alongside omalizumab, according to a study published in Medical Science Monitor. The study enrolled 61 patients with CU, 31 of whom received omalizumab with acupuncture and 30 omalizumab alone. The primary outcomes were the CU-Quality of Life (CU-QOL) and urticaria control test (UCT) scores, which were collected at baseline and after treatment. All participants received omalizumab 300 mg every four weeks. The acupuncture group ...